Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Transatlantic combined and comparative data analysis of 1095 patients with urea cycle disorders-a successful strategy for clinical research of rare diseases

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Increased risk of sudden death in untreated Primary Carnitine Deficiency

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Newborn screening for homocystinurias: recent recommendations versus current practice

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Increased risk of sudden death in untreated Primary Carnitine Deficiency

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Cystic fibrosis newborn screening in Denmark: Experience from the first 2 years

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Danish expanded newborn screening is a successful preventive public health programme

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Age-related renal function decline in Fabry disease patients on enzyme replacement therapy: a longitudinal cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Roland Posset
  • Sven F Garbade
  • Nikolas Boy
  • Alberto B Burlina
  • Carlo Dionisi-Vici
  • Dries Dobbelaere
  • Angeles Garcia-Cazorla
  • Pascale de Lonlay
  • Elisa Leão Teles
  • Roshni Vara
  • Nicholas Ah Mew
  • Mark L Batshaw
  • Matthias R Baumgartner
  • Shawn McCandless
  • Jennifer Seminara
  • Marshall Summar
  • Georg F Hoffmann
  • Stefan Kölker
  • Peter Burgard
  • Allan Meldgaard Lund (Medlem af forfattergruppering)
  • Additional individual contributors of the UCDC and the E-IMD consortium
Vis graf over relationer

BACKGROUND: To improve our understanding of urea cycle disorders (UCDs) prospectively followed by two North American (NA) and European (EU) patient cohorts.

AIMS: Description of the NA and EU patient samples and investigation of the prospects of combined and comparative analyses for individuals with UCDs.

METHODS: Retrieval and comparison of the data from 1095 individuals (NA: 620, EU: 475) from two electronic databases.

RESULTS: The proportion of females with ornithine transcarbamylase deficiency (fOTC-D), particularly those being asymptomatic (asfOTC-D), was higher in the NA than in the EU sample. Exclusion of asfOTC-D resulted in similar distributions in both samples. The mean age at first symptoms was higher in NA than in EU patients with late onset (LO), but similar for those with early (≤ 28 days) onset (EO) of symptoms. Also, the mean age at diagnosis and diagnostic delay for EO and LO patients were similar in the NA and EU cohorts. In most patients (including fOTC-D), diagnosis was made after the onset of symptoms (59.9%) or by high-risk family screening (24.7%), and less often by newborn screening (8.9%) and prenatal testing (3.7%). Analysis of clinical phenotypes revealed that EO patients presented with more symptoms than LO individuals, but that numbers of symptoms correlated with plasma ammonium concentrations in EO patients only. Liver transplantation was reported for 90 NA and 25 EU patients.

CONCLUSIONS: Combined analysis of databases drawn from distinct populations opens the possibility to increase sample sizes for natural history questions, while comparative analysis utilising differences in approach to treatment can evaluate therapeutic options and enhance long-term outcome studies.

OriginalsprogEngelsk
TidsskriftJournal of Inherited Metabolic Disease
Vol/bind42
Udgave nummer1
Sider (fra-til)96-106
Antal sider13
ISSN0141-8955
DOI
StatusUdgivet - 2019

ID: 56311767